Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats

European Journal of Nutrition

Volumn 57, Issue 7, 2018, Pages 2431-2444

  Chukwuma, Chika Ifeanyi ^a   Mopuri, Ramgopal ^a   Nagiah, Savania ^b   Chuturgoon, Anil Amichund ^b   Islam, Md Shahidul ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Erythritol; Glucose absorption; Glucose uptake; Glut 4; IRS 1; Type 2 diabetes (T2D)

Indexed keywords

ACARBOSE; BETA ACTIN; ERYTHRITOL; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HEXOKINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; MESSENGER RNA; ANTIDIABETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EX VIVO STUDY; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; PSOAS MUSCLE; RAT; SINGLE DRUG DOSE; STOMACH EMPTYING; STOMACH PARESIS; ANIMAL; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GASTROINTESTINAL ABSORPTION; METABOLISM; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ERYTHRITOL; GASTROINTESTINAL ABSORPTION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85026734881     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-017-1516-x     Document Type: Article

References (52)

1. Pratley RE (2013) The early treatment of type 2 diabetes. Am J Med 126:S2–S9
2. International Diabetes Federation (2015) IDF Diabetes Atlas, 7th edn
3. Bahrami J, Gerstein H (2016) The prevalence of undiagnosed type 2 diabetes on the General Medicine Ward. Can J Diabetes 40:S49–S50
4. Pratley R, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44:929–945
5. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 43:3–19
6. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW (1989) Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49:1155–1163
7. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ (2002) Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76:911–922
8. Astrup A, Raben A, Vasilaras TH, Moller AC (2002) Sucrose in soft drinks is fattening: a randomized 10 week study in overweight subjects. Am J Clin Nutr 7:405
9. Hu FB (2003) Sedentary lifestyle and risk of obesity and type 2 diabetes. Lipids 38:103–108
10. Amod A, Ascott-Evans BH, Berg GI et al (2012) The 2012 Society for Endocrinology, Metabolism and Diabetes of South Africa guideline for the management of type 2 diabetes. JEMDSA 17:1–95
11. Livesey G (2003) Health potential of polyols as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 16:163–191
12. Fitch C, Keim KS (2012) Position of the Academy of Nutrition and Dietetics: use of nutritive and non nutritive sweeteners. J Acad Nutr Diet 112:739–758
13. O’Donnell K, Kearsley MW (2012) Sweeteners and sugar alternatives in food technology, 2nd edn. Wiley, UK
14. Bornet FRJ, Blayo A, Dauchy F, Slama G (1996) Plasma and urine kinetics of erythritol after oral ingestion by healthy humans. Regul Toxicol Pharmaco 24:S280–S286
15. Yokozawa T, Kim HY, Cho EJ (2002) Erythritol attenuates the diabetic oxidative stress through modulating glucose metabolism and lipid peroxidation in streptozotocin-induced diabetic rats. J Agric Food Chem 50:5485–5489
16. Ishikawa M, Miyashita M, Kawashima Y et al (1996) Effects of oral administration of erythritol on patients with diabetes. Regul Toxicol Pharmacol 24:S303–S308
17. Flint N, Hamburg NM, Holbrook M et al (2014) Effects of erythritol on endothelial function in patients with type 2 diabetes mellitus: a pilot study. Acta Diabetol 51:513–516
18. Woelnerhanssen BK, Cajacob L, Keller N et al (2016) Gut hormone secretion, gastric emptying and glycemic responses to erythritol and xylitol in lean and obese subjects. Am J Physiol Endocrinol Metab 310:E1053–E1061
19. Chukwuma CI, Ibrahim MA, Islam MS (2016) Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study. J Physiol Biochem 72:791–801
20. Chukwuma CI, Islam MS (2017) Sorbitol increases muscle glucose uptake ex vivo and inhibits intestinal glucose absorption ex vivo and in normal and type 2 diabetic rats. Appl Physiol Nutr Metab 42:377–383
21. Wilson RD, Islam MS (2012) Fructose-fed streptozotocin injected rat: an alternative model for type 2 diabetes. Pharmacol Rep 64:129–139
22. Storey D, Lee A, Bornet F, Brouns F (2007) Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. Eur J Clin Nutr 61:349–354
23. Ngubane PS, Masola B, Musabayane CT (2011) The effects of Syzygium aromaticum derived oleanolic acid on glycogenic enzymes in streptozotocin induced-diabetic rats. Ren Fail 33:434–439
24. Lo S, Russel JC, Taylor AW (1970) Determination of glycogen in small tissue samples. J Appl Physiol 28:234–236
25. Sigma Aldrich (2016) Enzymatic assay of hexokinase. http://www.sigmaaldrich.com/technical-documents/protocols/biology/enzymatic-assay-of-hexokinase.html. Accessed 28 June 2016
26. Sigma Aldrich (2016) Enzymatic activity of glucose-6-phosphatase [EC 3.1.3.9]. http://www.sigmaaldrich.com/technical-documents/protocols/biology/enzymatic-assay-of-glucose-6-phosphatase.html. Accessed 2 July 2016
27. Rio DC, Ares M Jr., Hannon GJ, Nilsen TW (2010) Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc. doi:10.1101/pdb.prot5439
28. Araujo EP, Amaral ME, Filiputti E et al (2004) Restoration of insulin secretion in pancreatic islets of protein-deficient rats by reduced expression of insulin receptor substrate (IRS)-1 and IRS-2. J Endocrinol 181:25–38
29. Im SS, Kwon SK, Kang SY et al (2006) Regulation of GLUT4 gene expression by SREBP-1c in adipocytes. Biochem J 399:131–139
30. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:2002–2007
31. T method. Nat Protoc 3:1101–1108
32. Rider AK, Schedl HP, Nokes G, Shining S (1967) Small intestinal glucose transport. Proximal-distal kinetic gradients. J Gen Physiol 50:1173–1182
33. Riesenfeld G, Sklan D, Bar A, Eisner U, Hurwitz S (1980) Glucose absorption and starch digestion in the intestine of the chicken. J Nutr 110:117–121
34. Salminen E, Salminen S, Porkka L, Koivistoinen P (1984) The effects of xylitol on gastric emptying and secretion of gastric inhibitory polypeptide in the rat. J Nutr 114:2201–2203
35. Aronoff SL, Berkowitz K, Shreiner B, Want L (2004) Glucose metabolism and regulation: beyond insulin and glucagon. Diabetes Spectr 17:183–190
36. Horowitz M, Wishart JM, Jones KL, Hebbard GS (1996) Gastric emptying in diabetes: an overview. Diabet Med 13:S16–S22
37. Phillips WT, Schwartz JG, McMahan CA (1991) Rapid gastric emptying in patients with early non-insulin-dependent diabetes mellitus. N Engl J Med 324:130–131
38. Ranganath L, Norris F, Morgan L, Wright J, Marks V (1998) Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Diabet Med 15:120–124
39. Chukwuma CI, Islam MS (2015) Effects of xylitol on carbohydrate digesting enzymes activity, intestinal glucose absorption and muscle glucose uptake: a multi-mode study. Food Funct 6:955–962
40. Chang L, Chiang S, Saltiel AR (2004) Insulin signaling and the regulation of glucose transport. Mol Med 10:65–71
41. González-Sánchez JL, Serrano-Ríos M (2007) Molecular basis of insulin action. Drug News Perspect 20:527–531
42. Wu C, Khan SA, Lange AJ (2005) Regulation of glycolysis-role of insulin. Exp Gerontol 40:894–899
43. Fröjdö S, Vidal H, Pirola L (2009) Alterations of insulin signaling in type 2 diabetes: a review of the current evidence from humans. Biochim Biophys Acta 1792:83–92
44. Boucher J, Kleinridders A, Kahn CR (2014) Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a009191
45. Carvalho E, Jansson PA, Nagaev I, Wenthzel AM, Smith U (2001) Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J 15:1101–1103
46. Wang Y, Nishina PM, Naggert JK (2009) Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng. J Endocrinol 203:65–74
47. Gual P, Le Marchand-Brustel Y, Tanti J (2003) Positive and negative regulation of glucose uptake by hyperosmotic stress. Diabetes Metab 29:566–575
48. Zorzano A, Camps M (1997) Glut 4 in insulin resistance. In: Gould GW (ed) Facilitative glucose transporters. R.G. Landes Company and Chapman & Hall, US and Canada, pp 137–166. https://books.google.co.za/books?id = 4fpHl_KgxHIC&pg = PA149&lpg = PA149&dq = Postranslational + modification + of + Glut + 4&source = bl&ots = Dvs0Z6HTPs&sig = 35_nRLMKXpVUDGyEK00RU2UVbqM&hl = en&sa = X&ved = 0ahUKEwi79NnynvLUAhXKLMAKHfePDsYQ6AEIRjAG#v = onepage&q = Postranslational%20modification%20of%20Glut%204&f = false. Accessed 2 July 2017
49. Liu Z, Barrett EJ, Dalkin AC, Zwart AD, Chou JY (1994) Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level. Biochem Biophys Res Commun 205:680–686
50. Lenzen S (2014) A fresh view of glycolysis and glucokinase regulation: history and current status. J Biol Chem 289:12189–12194
51. Clore JN, Stillman J, Sugerman H (2000) Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49:969–974
52. Kruszynska YT, Home PD (1988) Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in a rat model of non-insulin-dependent diabetes. Diabetologia 31:304–309